The methylene blue available in pharmacy is a chemical compound with multiple medical applications, officially recognized for over a century. We are seeing renewed interest in this substance, both for its established therapeutic uses and for the promising research that is underway. This versatile molecule deserves your attention, whether you are in a health prevention approach or are seeking to understand its medical applications.
Let's explore together:
- Characteristics and available pharmaceutical forms
- Validated medical applications and their protocols
- Precautions essential to respect
- Recent research into its potential benefits
- Practical tips for safe use
What is methylene blue in pharmacy?
Methylene blue, also known as methylthioninium chloride, is one of the oldest chemical dyes used in medicine. Discovered in 1876 by the German chemist Heinrich Caro, this compound has a fascinating characteristic: it appears as a dark green crystalline powder, but produces an aqueous solution of an intense blue characteristic.
This substance is applied in many medical fields. The pharmacies now offer standardised preparations, which are controlled according to the European pharmacopoeia, guaranteeing optimal purity and safety. Its molecular formula C16H18ClN3S·2H2O gives it unique properties, including its ability to interact specifically with biological systems.
We consider methylene blue as a medicine in its own right, requiring the same precautions as any other drug product. Its regulatory status varies from country to country, but it is generally available on prescription or pharmaceutical advice in most pharmacies.
Composition and forms available in pharmacy
The pharmacies offer several galenic forms of methylene blue, adapted to different medical uses. Sterile solutions are the most common form, available in 2 ml ampoules at a concentration of 0.5% for hospital use, including ProveDye referenced in Vidal.
For ambulatory applications, we find 60 ml to 1% bottles marketed by Croix Blanche Pharma, as well as 100 ml packs with the same concentration. These preparations meet strict purity standards: absence of preservatives, artificial additives and genetically modified organisms.
Packaging is of particular importance. Manufacturers use only brown or amber glass bottles equipped with drop pipettes for a precise dosage. This protection against light preserves the stability of the active substance and maintains its therapeutic properties. The molecular weight of 355.9 g/mol allows complete dissolution in purified water, ensuring optimal bioavailability.
The main medical uses of methylene blue
In diagnostic surgery, methylene blue reveals its major usefulness in visualizing the sentinel ganglion. This technique, which is used for breast, thyroid, endometrial and certain melanoma cancers, accurately identifies the first ganglion relay draining a tumour. Surgeons inject locally a diluted solution that migrates to the affected ganglion, facilitating its identification and biopsy.
The diagnostic applications extend to the detection of fistulous routes and the leakproof testing of surgical sutures. In these contexts, we observe an intense blue coloration that reveals possible leaks or abnormal communications between the organs. This technique is particularly valuable in digestive and urological surgery.
Therapeutically, methylene blue effectively treats methemoglobinemia, a condition where hemoglobin loses its ability to transport oxygen. Intravenous administration of 1 to 2 mg/kg body weight allows rapid correction of this potentially fatal abnormality. We also use it as an antidote in some cyanide poisonings, where it acts as a restaurant of the cellular respiratory chain.
Other applications studied and ongoing research
Contemporary research explores promising applications of methylene blue in several advanced medical fields. In oncology, studies focus on its specific cytotoxic effects against tumour cells. The mechanism of action involves the controlled production of free radicals and the disruption of the energy metabolism of cancer cells, opening interesting therapeutic perspectives.
In neurology, we follow closely the work on Alzheimer's disease and Parkinson's disease. Preliminary research suggests that methylene blue may improve cognitive functions and slow the progression of certain neurodegenerative symptoms. These effects would be explained by its action on neuronal mitochondria and the reduction of oxidative stress.
Psychiatry also explores its antidepressant potential. Historical studies have shown that at low doses (15-60 mg daily), methylene blue may have beneficial effects on severe depressions resistant to conventional treatments. This research remains experimental and requires rigorous clinical protocols.
How to use methylene blue safely
The use of methylene blue requires adherence to precise protocols to ensure your safety. Administration is exclusively under qualified medical supervision, never self-medication. For local or peritumoral injections, dilutions in NaCl 0.9% physiological serum are recommended, with varying concentrations as indicated: 0.01% to 2.5 mg/ml.
The dosage is a determining factor. For methemoglobinaemia, the standard dose of 1 to 2 mg/kg in slow intravenous injection allows optimal efficacy while minimizing risks. This should be done over 5 to 10 minutes, never in direct bolus, which could cause serious cardiovascular complications.
The preparation of solutions requires special precautions. Use only freshly prepared dilutions, never stored solutions after opening the vial. Microbial contamination is a major risk, and therefore it is important to follow the surgical rules when handling.
Contraindications and possible side effects
Some medical situations formally prohibit the use of methylene blue. The glucose-6-phosphate dehydrogenase (G6PD) deficiency is an absolute contraindication, as this enzyme protects red blood cells from hemolysis. Patients with this genetic anomaly risk massive destruction of their hematia with potentially fatal consequences.
Drug interactions require special vigilance. The recent use of serotonergic antidepressants (SSRI, NSRI, MAO, venlafaxine, mirtazapine) contraindicates administration of methylene blue for at least 14 days. This combination can trigger a serious serotonin syndrome, characterized by hyperthermia, muscle stiffness and unconsciousness.
We strongly advise against its use during pregnancy and breastfeeding. Safety studies remain insufficient to ensure that there are no foetal or neonatal risks. Renal impairment also requires special care, with dose adjustment according to creatinine clearance.
Precautions and storage in pharmacy
The conservation of methylene blue meets strict requirements to maintain its therapeutic effectiveness. Keep the vials at room temperature, ideally between 15 and 25°C, without ever exposing them to the gel that would permanently alter the formulation. Freezing causes irreversible chemical changes making the product unusable.
Protection against light is an absolute imperative. Always store the vials in their original packaging or in a dark place. UV exposure rapidly degrades the active substance and can generate toxic by-products. This photosensitivity explains why all pharmaceutical packs use tinted glass.
When purchasing a pharmacy, always check the expiry date and packaging integrity. A vial with traces of crystallization or abnormal colouring should be refused. Require test certificates if you use the product in a professional setting, ensuring traceability and compliance with pharmaceutical standards.
Health professional opinions on methylene blue
Hospital physicians recognize the indisputable usefulness of methylene blue in its validated indications. Oncological surgeons plebiscite its efficacy in the sentinel ganglion technique, with a detection success rate greater than 90% in recent clinical studies. This reliability makes it a reference diagnostic tool in many surgical protocols.
Emergency workers stress its vital role in the treatment of methemoglobinemia. Its rapid action, with a clinical improvement that can be observed in 30 to 60 minutes, can literally save lives. Resuscitation services systematically maintain emergency stocks to deal with accidental or occupational poisoning.
However, practitioners stress the need for specific training before any use. Side effects, although rare when protocols are respected, may be serious in cases of misuse. This competency requirement explains why some applications remain reserved for the specialized hospital community.
Where to find methylene blue in pharmacy and at what price?
Drugstores can usually order methylene blue on request, although it is not always in permanent stock. Supply times vary from 24 to 72 hours depending on the distributor. We recommend contacting your pharmacist in advance to ensure availability, especially if you live in a less densely populated area.
Prices vary according to packaging and laboratories. Count about 25 to 40 euros for a bottle of 60 ml to 1 %, and 35 to 55 euros for a volume of 100 ml. 2 ml hospital bulbs usually cost between 15 and 25 euros per unit. These tariffs remain accessible given the specificity of the product and the quality controls required.
For healthcare professionals, specialist distributors offer hospital packaging with preferential rates. In-patient pharmacies benefit from dedicated supply channels, guaranteeing permanent availability for medical emergencies.
| Pharmaceutical form | Concentration | Volume | Approximate price | Main use |
| Sterile bulbs | 0,5 % | 2 ml | 15-25 € | Hospital surgery |
| Dropper bottle | 1 % | 60 ml | 25-40 € | Outpatient medical use |
| Standard bottle | 1 % | 100 ml | 35-55 € | Therapeutic applications |
Methylene blue deserves its place in the modern therapeutic arsenal, provided that medical indications and precautions are scrupulously observed. Its therapeutic potential, validated by decades of clinical use and enriched by contemporary research, makes it a valuable ally for many pathologies. However, caution remains to be exercised: always consult a qualified health care professional before use.
